Mark Rackham

Mark Rackham has diverse work experience in the pharmaceutical and research industries. Mark served as the Head of Exploratory Sciences and Distinguished Researcher at Isomorphic Labs since 2023. Prior to that, Mark worked at MSD as a Director from October 2021 to January 2023 and as an Associate Principal Scientist from September 2019 to October 2021. Before joining MSD, they held positions at BenevolentAI as the VP of Drug Discovery from October 2018 to September 2019, and as a Drug Discovery Scientist from October 2017 to October 2018. Mark also worked at GSK as an Investigator from May 2016 to October 2017, an International Assignment from January 2017 to June 2017, and as a Medicinal Chemist from August 2014 to May 2016. Mark started their career at Sosei Heptares as a Post-Doctoral Research Scientist from October 2013 to August 2014. Mark also has research experience from Imperial College London as a Post-Doctoral Research Associate from November 2012 to October 2013 and as a PhD Student from October 2009 to October 2012. Additionally, they gained industry exposure as an Industrial Placement Student at GlaxoSmithKline from October 2007 to September 2008.

Mark Rackham completed their education with a PhD in Medicinal Chemistry from Imperial College London in 2012. Prior to that, they obtained a 1st Class Master of Chemistry (Honours) degree in Chemistry from The University of Edinburgh from 2004 to 2009. Mark'searlier education includes attending Belmont Academy, Ayr from 1998 to 2004, but no specific degree or field of study is mentioned for this period.